Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314183 · ClinicalTrials.gov registry record · Phase 2
Enhancing the Effectiveness of Physical Therapy for People With Knee Osteoarthritis
A Phase 2 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- Completed
- Registry status
- Phase 2
- Development phase
- 300
- Enrollment target
NCT01314183: Completed Phase 2 study, sponsored by Agency for Healthcare Research and Quality (AHRQ).
NCT01314183 is a Phase 2 study that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 300 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (126% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01314183, a Phase 2 study, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 300 participants
- Enrollment target
Study Summary
The overall aim of the project is to examine the clinical and cost-effectiveness of utilizing booster sessions(periodic face-to-face follow-up appointments that take place several weeks or months following discharge from the supervised therapy program designed to review the patient's current rehabilitation program, troubleshoot any problems with the program, and make recommendations for program progression or modification) in the delivery of exercise therapy, and supplementing exercise therapy with manual therapy techniques(manually applied treatment techniques such as joint mobilization/manipulation, manual traction, soft tissue manipulations, passive stretching and range of motion). The investigators will do this in a randomized, multi-center, clinical trial. The investigators hypothesize that adding manual therapy techniques will be more clinically effective than exercise alone and that using booster sessions will maintain longer term clinical effects and be more cost-effective than not using booster sessions.
Primary Outcome
Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.
Interventions
- OTHER Exercise
- OTHER manual therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
What the finished NCT01314183 record still lists
NCT01314183 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (126% higher).
The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.
NCT01314183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01314183 about?
NCT01314183 is a clinical study titled "Enhancing the Effectiveness of Physical Therapy for People With Knee Osteoarthritis". The overall aim of the project is to examine the clinical and cost-effectiveness of utilizing booster sessions(periodic face-to-face follow-up appointments that take place several weeks or months following discharge from the supervised therapy program designed to review the patient's current rehabil...
What is the current status of trial NCT01314183?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 300 participants. The study started on 2011-04. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01314183?
The interventions under investigation include: Exercise (OTHER), manual therapy (OTHER).
Who is sponsoring clinical trial NCT01314183?
This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01314183's enrollment target sits among peer trials
300 167th of 2000 higher than 1,813 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia